查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722933

2025 年至 2033 年静脉曲张治疗市场规模、份额、趋势及预测（按产品、程序、最终用户和地区）

Varicose Vein Treatment Market Size, Share, Trends and Forecast by Product, Procedure, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球静脉曲张治疗市场规模价值 4.588 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 6.969 亿美元，2025 年至 2033 年的复合年增长率为 4.52%。北美目前占据市场主导地位，到 2024 年其市占率将超过 47.8%。老龄人口的成长、微创 (MI) 手术的技术进步、人们意识的提高和医疗保健支出的增加，以及主要参与者专注于创新和策略合作以扩大治疗选择和地理覆盖范围，这些都是推动市场成长的一些因素。

静脉曲张治疗市场分析：

主要市场驱动因素：由于老龄人口中静脉曲张盛行率的上升以及治疗技术的进步，市场正在经历适度增长。

主要市场趋势：与传统手术方法相比，人们开始转向微创治疗方法，因为它们更有效、更能减轻疼痛、恢復期更短。除此之外，影像技术在静脉曲张治疗中的日益融合，提高了治疗和结果的精确度，促进了市场的成长。

地理趋势：北美占据市场主导地位，这得益于高昂的医疗支出、先进的医疗基础设施以及大众对静脉曲张疾病认识的不断提高。

竞争格局：静脉曲张治疗行业的主要市场参与者包括 Alma Lasers Ltd.（Sisram Medical Ltd.）、Angiodynamics Inc.、Biolitec AG（BioMed Technology Holdings Ltd.）、Boston Scientific Corporation、Eufoton SRL、Fotona、Medtronic plc、Sciton Inc.、Teleflex Incorporated、Theeleflex P.

挑战与机会：先进的静脉曲张治疗费用不断上涨，对于没有足够保险覆盖的患者来说，尤其是在欠发达地区，这可能会影响市场收入。然而，这也为产业参与者创造了机会来开发可负担的解决方案，让更广泛的人群能够获得治疗。此外，获得更多健康知识是静脉曲张治疗市场近期的主要发展之一，旨在让潜在患者了解各种治疗方案，并扩大潜在客户群。

静脉曲张治疗市场趋势：

治疗技术的进步

静脉内雷射治疗 (EVLT)、射频消融 (RFA) 和超音波导引硬化疗法等持续的进步正在将治疗方法从侵入性手术转变为微创 (MI) 和非手术选择。对于患者来说，这些新技术可以带来更快的恢復、更少的痛苦、以及更小的术后併发症发生率，这使得手术越来越受欢迎。 2023年全球微创手术市场规模为529亿美元。根据IMARC Group的报告，预计到 2032 年市场规模将达到 910 亿美元，2024-2032 年期间的复合年增长率为 6%。雷射和射频设备与影像技术的结合进一步发展，可以对患病静脉进行更精确的治疗，从而推动静脉曲张治疗的需求。公司正在将其收入用于研发（R&D），以充分利用现有技术并提出新的创新。

医疗保健全球化

透过国际合作，医疗保健专业人员可以交流最佳实践和技术，从而提高全球治疗品质。例如，VVT Medical 宣布与 Methapharm 达成策略性分销协议，在 2023 年 6 月获得 FDA 批准后，在美国销售其 ScleroSafe 平台。此次合作利用 Methapharm 在静脉曲张方面的专业知识，旨在透过 ScleroSafe 的创新、非热、非肿胀技术改变治疗方法。这种全球性的交流保证了不同地区能够获得先进的治疗技术，并实现护理品质的标准化，从而支持静脉曲张治疗市场的成长。医疗旅游也是一个因素，患者前往海外寻求更实惠的一流治疗。 2023年，全球医疗旅游产业价值为1,197亿美元。 IMARC Group估计，从 2024 年到 2032 年，市场规模将以 20.1% 的复合年增长率扩张，到 2032 年达到 6508 亿美元。全球化将提高全球静脉曲张治疗的可及性和质量，从而支持市场扩张和技术进步。

监管部门的批准和支持

获得监管部门的批准和支持对于推动静脉曲张治疗的发展至关重要。监管机构为新医疗设备和治疗方法制定了严格的标准并提供明确的审批程序。严格的监管环境促使公司投资研究和临床试验以推动创新。当局对治疗方法的批准建立了医疗保健提供者和患者之间的信任和信心，保证了市场上有安全有效的选择。此外，强而有力的法规可以加速尖端治疗方法进入市场，加快其采用并扩大静脉曲张治疗的现代选择范围。 2024 年 4 月，VVT Medical 的 ScleroSafe(TM) 设备获得韩国食品药物安全部的批准，在韩国市场取得了重大里程碑。这是在获得 FDA 510(k) 批准和 CE 标誌后，确认 ScleroSafe(TM) 是治疗静脉曲张的可靠选择。

静脉曲张治疗市场细分：

按产品分类：

  • 消融设备
  • 射频消融设备
  • 雷射烧蚀设备
  • 其他的
  • 硬化疗法注射
  • 其他的

消融设备是一个重要的部分，尤其是射频和雷射消融设备，因为它们是治疗静脉曲张的首选。这些方法可以有效地关闭有问题的静脉，而且比迄今为止使用的方法侵入性更小，从而减少疼痛并使患者快速康復。射频消融设备利用热能加热并压塌静脉，而雷射消融则利用光能达到类似的效果，为喜欢微创治疗的患者提供有效的选择。 2023年全球消融设备市场规模达59亿美元。 IMARC Group预测，到 2032 年，该市场的价值将达到 144 亿美元，2024 年至 2032 年期间的复合年增长率为 10.2%。

硬化疗法注射在业界占有重要地位，进而影响静脉曲张治疗市场的收入。该技术包括将溶液注射到静脉曲张，从而形成疤痕并将血液重新引导至更健康的静脉，最终导致被治疗的静脉消失。该技术之所以被采用，是因为它能够有效治疗轻微静脉曲张和蜘蛛网状静脉，并且易于使用且成本合理。它在门诊环境中尤其受欢迎，因为快速康復是一个重要因素。

其他包括一系列附加选择，例如压力袜和外科手术。压力袜通常用作非手术方法来控制症状并延缓静脉曲张的进展，特别是在初期或轻微情况下。虽然由于微创（MI）技术的增加，手术现在使用得越来越少，但在其他治疗方法无效的严重情况下，手术仍然会被使用。该部分服务于广泛的患者，提供从基本的预防保健到广泛的外科治疗的选择。

依程序分解：

  • 注射硬化疗法
  • 静脉内消融术
  • 手术结扎和剥离

注射硬化疗法占业界最大份额

注射硬化疗法是静脉曲张治疗产业中最主要的领域，主要是因为其有效性、低侵入性以及成本效益。该过程包括将硬化剂溶液注入静脉曲张，以刺激静脉壁，导致其塌陷和黏合。随着时间的推移，接受治疗的静脉会逐渐消失并被周围组织吸收。硬化疗法之所以受欢迎，是因为它可以在门诊进行，可以快速解决美容问题以及小静脉曲张和蜘蛛静脉引起的不适，并且恢復时间短，使其成为既想要有效又想要方便的患者的首选。 2023年，全球硬化疗法市场价值为12亿美元。 IMARC Group预测，2024 年至 2032 年期间，市场规模将以 5.5% 的年复合成长率(CAGR) 扩张，到 2032 年将达到 20 亿美元。

按最终用户分类：

  • 医院
  • 诊所
  • 流动中心

医院是主要的细分市场

医院凭藉其广泛的治疗选择和处理需要高级医疗干预的复杂病例的能力占据市场主导地位，从而塑造了积极的静脉曲张治疗市场前景。他们拥有提供各种静脉曲张治疗所需的基础设施，包括硬化疗法和静脉内消融等侵入性较小的手术，以及手术结扎和剥离等侵入性较大的技术。该科室为寻求专业血管外科医生和介入放射科医生提供可靠、有效治疗的患者带来了极大的信心。此外，医院在治疗中发挥关键作用，对于需要各种医疗保健提供者的全面护理和长期监测的晚期静脉曲张患者来说，医院往往是他们的首选，从而巩固了其在市场上的地位。

按地区划分：

  • 北美洲
  • 美国
  • 加拿大
  • 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

北美引领市场，占据静脉曲张治疗市场最大份额

该报告还对所有主要区域市场进行了全面的分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。根据报告，北美是静脉曲张治疗最大的区域市场。

北美占据最大的市场份额，这主要归功于其大量的医疗保健支出、先进的医疗技术和完善的医疗保健系统。该地区涵盖美国和加拿大，由于老年居民中静脉曲张患者数量较多，因此对微创 (MI) 手术的需求很高。根据2023年美国人口普查局的报告，美国65岁及以上人口数量预计将从2022年的5,800万人增加47%，到2050年增加到8,200万人。此外，预计该年龄层人口在总人口中的比例将从17%上升到23%。此外，北美拥有顶尖的医疗保健公司和强大的监管框架，鼓励快速采用新技术，具有优势。该地区在全球市场的强大影响力也受到其广泛的保险覆盖范围和高度的患者意识的影响。

竞争格局：

市场研究报告也对市场竞争格局进行了全面的分析。也提供了所有主要公司的详细资料。该行业的一些主要市场参与者包括 Alma Lasers Ltd. (Sisram Medical Ltd.)、Angiodynamics Inc.、Biolitec AG (BioMed Technology Holdings Ltd.)、Boston Scientific Corporation、Eufoton SRL、Fotona、Medtronic plc、Sciton Inc.、Teleflex Incorporated、The Vein Company Ltd、V. Medical.H. Medical.H.

本报告回答的关键问题

  • 什么是静脉曲张治疗
  • 静脉曲张治疗市场有多大
  • 2025-2033年全球静脉曲张治疗市场的预期成长率是多少
  • 推动全球静脉曲张治疗市场的关键因素有哪些
  • 根据治疗程序，全球静脉曲张治疗市场的主要细分领域是什么
  • 根据最终用户来看，全球静脉曲张治疗市场的主要细分市场是什么
  • 全球静脉曲张治疗市场的主要地区有哪些
  • 全球静脉曲张治疗市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 什么是静脉曲张治疗？静脉曲张治疗市场有多大？
  • 2025 年至 2033 年期间全球静脉曲张治疗市场的预期成长率为何？
  • 推动全球静脉曲张治疗市场发展的关键因素有哪些？
  • 根据程序，全球静脉曲张治疗市场的主要部分是什么？
  • 根据最终用户来看，全球静脉曲张治疗市场的领先细分市场是什么？
  • 全球静脉曲张治疗市场的主要地区有哪些？
  • 全球静脉曲张治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球静脉曲张治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 消融设备
    • 关键部分
      • 射频消融设备
      • 雷射烧蚀设备
      • 其他的
  • 硬化疗法注射
  • 其他的

第七章：市场区隔：依程序

  • 注射硬化疗法
  • 静脉内消融术
  • 手术结扎和剥离

第八章：市场区隔：按最终用户

  • 医院
  • 诊所
  • 流动中心

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alma Lasers Ltd. (Sisram Medical Ltd.)
    • Angiodynamics Inc.
    • Biolitec AG (BioMed Technology Holdings Ltd.)
    • Boston Scientific Corporation
    • Eufoton SRL
    • Fotona
    • Medtronic plc
    • Sciton Inc.
    • Teleflex Incorporated
    • The Vein Company
    • VVT Medical Ltd.
    • WON TECH Co. Ltd
Product Code: SR112025A5494

The global varicose vein treatment market size was valued at USD 458.8 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 696.9 Million by 2033, exhibiting a CAGR of 4.52% from 2025-2033. North America currently dominates the market, holding a market share of over 47.8% in 2024. The growing elderly population, technological advancements in minimally invasive (MI) procedures, increasing awareness and healthcare spending, and key players focusing on innovation and strategic collaborations to expand treatment options and geographic reach are some of the factors impelling the market growth.

Varicose Vein Treatment Market Analysis:

Major Market Drivers: The market is experiencing moderate growth because of the rising prevalence of varicose veins among the aging population and advancements in treatment technologies.

Key Market Trends: There is a shift towards less invasive treatment methods because of their efficacy, reduced pain, and shorter recovery periods compared to traditional surgical methods. Besides this, the growing integration of imaging technologies in varicose vein treatments, which enhances the precision of treatments and outcomes, is contributing to the growth of the market.

Geographical Trends: North America dominates the market, driven by high healthcare expenditure, advanced medical infrastructure, and increasing awareness about varicose vein conditions among the masses.

Competitive Landscape: Some of the major market players in the varicose vein treatment industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd., among many others.

Challenges and Opportunities: The growing cost of advanced varicose vein treatments, which can be prohibitive for patients without adequate insurance coverage, particularly in less developed regions, is influencing the market revenue. Nevertheless, this also creates a chance for industry participants to develop affordable solutions that can increase the availability of treatments to a wider range of people. Moreover, gaining more knowledge about health presents one of the major varicose vein treatment market recent developments to inform potential patients about the various treatment options, broadening the potential customer base.

Varicose Vein Treatment Market Trends:

Technological Advancements in Treatment

Ongoing advancements like endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and ultrasound-guided sclerotherapy are changing treatment approaches from invasive surgeries to minimally invasive (MI) and non-surgical options. For patients, such new technologies promise quicker recovery, less pain, and smaller chances of post-operation complications, which is causing the popularity of the surgeries to grow. In 2023, the size of the global minimally invasive surgery market was US$ 52.9 Billion. As per the report by the IMARC Group, the market is expected to reach US$ 91.0 Billion by 2032, exhibiting a CAGR of 6% during 2024-2032. Further development of lasers and radiofrequency devices in combination with imaging technologies for more pinpoint treatment in the ailing veins is driving the varicose vein treatment demand. Companies are channelizing their revenues for research and development (R&D) to make the best use of technologies existing and to come up with new innovations.

Globalization of Healthcare

By partnering internationally, healthcare professionals exchange best practices and technologies, enhancing the quality of treatment globally. For instance, VVT Medical announced a strategic distribution agreement with Methapharm to market its ScleroSafe platform in the USA, following FDA approval in June 2023. This collaboration leverages Methapharm's expertise in varicose veins, aiming to transform treatment with ScleroSafe's innovative, non-thermal, non-tumescent technique. This worldwide exchange guarantees that advanced treatment techniques are available in different areas with standardization of care quality, supporting the varicose vein treatment market growth. Medical tourism is also a factor, with patients traveling overseas in search of top-notch treatments at more affordable prices. In 2023, the medical tourism industry in the world was valued at US$119.7 billion. The IMARC Group estimates the market would expand at a CAGR of 20.1% from 2024 to 2032, reaching US$ 650.8 billion in 2032. Globalization leads to increased accessibility and improved quality of varicose vein treatments worldwide, supporting market expansion and technological progress.

Regulatory Approvals and Support

Obtaining regulatory approvals and support is essential for advancing the development of varicose vein treatment. Regulatory agencies establish stringent criteria and provide clear approval procedures for new medical devices and treatments. The strict regulatory landscape motivates companies to invest in research and clinical trials to drive innovation. The approval of treatments by authorities builds trust and confidence between healthcare providers and patients, guaranteeing the presence of secure and efficient choices in the market. Furthermore, robust regulations can accelerate the entry of cutting-edge treatments into the market, quickening their adoption and expanding the range of modern options for varicose vein treatment. In April 2024, VVT Medical achieved a major milestone in the Korean market with the approval of its ScleroSafe(TM) device by the Korean Ministry of Food and Drug Safety. This was after the FDA 510(k) clearance and CE Mark, confirming ScleroSafe(TM) as a dependable option for varicose vein treatment.

Varicose Vein Treatment Market Segmentation:

Breakup by Product:

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Others
  • Sclerotherapy Injection
  • Others

Ablation devices are an important segment, especially radiofrequency and laser ablation devices, because they are preferred in the treatment of varicose veins. These are effective in shutting off problematic veins with ways that are less invasive than those used hitherto, thereby inflicting less pain and delivering the patient to recovery quickly. Radiofrequency ablation devices utilize thermal energy to heat and collapse the vein, while laser ablation uses light energy to accomplish similar outcomes, providing effective options for patients who prefer less invasive treatments. In 2023, the market size of ablation devices worldwide reached US$ 5.9 billion. IMARC Group forecasts that the market will reach a value of US$ 14.4 billion by 2032, showing a 10.2% CAGR from 2024 to 2032.

Sclerotherapy injections have a solid presence in the industry, thereby influencing the varicose vein treatment market revenue. This technique includes injecting a solution into the varicose veins, which results in scarring and redirecting blood to healthier veins, ultimately causing the treated vein to vanish. The technique is used because of its effectiveness in addressing minor varicose veins and spider veins, its ease of use, and its reasonable cost. It is particularly popular in outpatient settings, where fast recovery is an important factor.

Others encompass a range of additional options, such as compression stockings and surgical procedures. Compression stockings are often utilized as a non-surgical method to control symptoms and delay the advancement of varicose veins, especially in the initial phases or mild instances. Surgical procedures, while less frequently used now because of the increase in minimally invasive (MI) techniques, are still utilized in serious situations when other treatments do not work. This part serves a wide range of patients, providing options from basic preventive care to extensive surgical treatments.

Breakup by Procedure:

  • Injection Sclerotherapy
  • Endovenous Ablation
  • Surgical Ligation and Stripping

Injection sclerotherapy holds the largest share of the industry

Injection sclerotherapy is the most dominant sector in the varicose vein treatment industry, mainly because of its effectiveness, low level of invasiveness, and cost-effectiveness. The process includes injecting a sclerosant solution into the varicose veins to irritate the vein walls, leading them to collapse and bond. As time passes, the vein that has been treated fades away as it gets absorbed back into the surrounding tissue. The popularity of sclerotherapy is enhanced by its ability to be performed in outpatient settings, its quick resolution of cosmetic concerns and discomfort from small varicose and spider veins, and its short recovery time, making it a preferred option for patients wanting both effectiveness and convenience. In 2023, the sclerotherapy market in the world was valued at US$ 1.2 billion. The IMARC Group projects that the market will expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, when it reaches US$ 2.0 billion in 2032.

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Centers

Hospitals represents the leading market segment

Hospitals dominate the market due to their extensive treatment options and ability to manage complicated cases that require advanced medical interventions, shaping a positive varicose vein treatment market outlook. They have the required infrastructure to offer various types of treatments for varicose veins, including less invasive procedures like sclerotherapy and endovenous ablation and more aggressive techniques such as surgical ligation and stripping. This section benefits a strong level of confidence from patients who are looking for dependable and efficient treatments from specialized vascular surgeons and interventional radiologists. Moreover, hospitals play a key role in are frequently the top choice for patients with advanced varicose veins who may need comprehensive care from various healthcare providers and extended monitoring, solidifying their position in the market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest varicose vein treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for varicose vein treatment.

North America holds biggest share in the market, mainly due to substantial healthcare expenditure, cutting-edge medical technologies, and a solid healthcare system. This area, encompassing both the United States and Canada, shows a high need for minimally invasive (MI) procedures because of a high number of varicose veins in its elderly residents. As per the 2023 US Census Bureau report, the number of people in the US aged 65 and above was projected to increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, it is expected that the percentage of people in this age range in the overall population will rise from 17% to 23%. Furthermore, North America is advantaged by having top healthcare firms and a strong regulatory framework that encourages quick uptake of new technologies. The strong presence of the region in the global market is also influenced by its extensive insurance coverage and high level of patient consciousness.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.

Key Questions Answered in This Report

  • 1.What is varicose vein treatment?
  • 2.How big is the varicose vein treatment market?
  • 3.What is the expected growth rate of the global varicose vein treatment market during 2025-2033?
  • 4.What are the key factors driving the global varicose vein treatment market?
  • 5.What is the leading segment of the global varicose vein treatment market based on procedure?
  • 6.What is the leading segment of the global varicose vein treatment market based on end user?
  • 7.What are the key regions in the global varicose vein treatment market?
  • 8.Who are the key players/companies in the global varicose vein treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Varicose Vein Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ablation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Radiofrequency Ablation Devices
      • 6.1.2.2 Laser Ablation Devices
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Sclerotherapy Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Injection Sclerotherapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endovenous Ablation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Surgical Ligation and Stripping
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Angiodynamics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biolitec AG (BioMed Technology Holdings Ltd.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eufoton S.R.L.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Fotona
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sciton Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teleflex Incorporated
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Vein Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 VVT Medical Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 WON TECH Co. Ltd
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Varicose Vein Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Varicose Vein Treatment Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Varicose Vein Treatment Market: Breakup by Procedure (in %), 2024
  • Figure 6: Global: Varicose Vein Treatment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Varicose Vein Treatment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Varicose Vein Treatment (Ablation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Varicose Vein Treatment (Ablation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Varicose Vein Treatment (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Varicose Vein Treatment (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Varicose Vein Treatment (Endovenous Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Varicose Vein Treatment (Endovenous Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Varicose Vein Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Varicose Vein Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Varicose Vein Treatment (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Varicose Vein Treatment (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Varicose Vein Treatment (Ambulatory Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Varicose Vein Treatment (Ambulatory Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Varicose Vein Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Varicose Vein Treatment Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Varicose Vein Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Varicose Vein Treatment Industry: SWOT Analysis
  • Figure 76: Global: Varicose Vein Treatment Industry: Value Chain Analysis
  • Figure 77: Global: Varicose Vein Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Varicose Vein Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Varicose Vein Treatment Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Varicose Vein Treatment Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 4: Global: Varicose Vein Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Varicose Vein Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Varicose Vein Treatment Market: Competitive Structure
  • Table 7: Global: Varicose Vein Treatment Market: Key Players